Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE DU PONT DE GOURNAY : revenue, balance sheet and financial ratios

PHARMACIE DU PONT DE GOURNAY is a French company founded 18 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in GOURNAY-SUR-MARNE (93460), this company of category PME shows in 2024 a net income positive of 109 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE DU PONT DE GOURNAY (SIREN 500736277)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue N/C N/C N/C N/C N/C N/C N/C N/C N/C
Net income 109 491 € 67 172 € 185 836 € 146 043 € 78 221 € 88 429 € 47 494 € 56 520 € 42 786 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2024, PHARMACIE DU PONT DE GOURNAY generates positive net income of 109 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 43 k€ -> 109 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

109 491 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 66%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 54%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

65.722%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

53.562%

Solvency indicators evolution
PHARMACIE DU PONT DE GOURNAY

Sector positioning

Debt ratio
65.72 2024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average

In 2024, the debt ratio of PHARMACIE DU PONT DE GOURNAY (65.72) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
53.56% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good +11 pts over 3 years

In 2024, the financial autonomy of PHARMACIE DU PONT DE GOURNAY (53.6%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Positioning of PHARMACIE DU PONT DE GOURNAY in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of PHARMACIE DU PONT DE GOURNAY is estimated at 1 528 575 € (range 1 064 475€ - 2 286 836€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
1064k€ 1528k€ 2286k€
1 528 575 € Range: 1 064 475€ - 2 286 836€
NAF 5 année 2024

Valuation method used

Net Income Multiple
109 491 € × 14.0x = 1 528 575 €
Range: 1 064 476€ - 2 286 836€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE DU PONT DE GOURNAY with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE DU PONT DE GOURNAY

What is the revenue of PHARMACIE DU PONT DE GOURNAY ?

The revenue of PHARMACIE DU PONT DE GOURNAY is not publicly disclosed (confidential accounts filed with INPI).

Is PHARMACIE DU PONT DE GOURNAY profitable?

Yes, PHARMACIE DU PONT DE GOURNAY generated a net profit of 109 k€ in 2024.

Where is the headquarters of PHARMACIE DU PONT DE GOURNAY ?

The headquarters of PHARMACIE DU PONT DE GOURNAY is located in GOURNAY-SUR-MARNE (93460), in the department Seine-Saint-Denis.

Where to find the tax return of PHARMACIE DU PONT DE GOURNAY ?

The tax return of PHARMACIE DU PONT DE GOURNAY is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE DU PONT DE GOURNAY operate?

PHARMACIE DU PONT DE GOURNAY operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.